The finding that we did not observe obvious clinical signs of CHH in any of the heterozygous WDR11 carriers questions an association between heterozygous WDR11 variants and CHH [1, 3, 8], however, specific variants in WDR11 might exert different effects in humans. This evidence concerns the gene WDR11 and cartilage-hair hypoplasia.